ALVESCO: payments to doctors
Payments that named ALVESCO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $274K
- Providers
- 3,136
- Transactions
- 9,277
- Average per transaction
- $30
The per-transaction average — $30 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,136 providers the average total is $87, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Covis Pharma GmbH | $124,034 | 45.3% |
| Covis Pharma B.v. | $111,048 | 40.6% |
| Azurity Pharmaceuticals, Inc. | $38,733 | 14.1% |